Regular aspirin use tied to lower risk for digestive tract cancers

Regular aspirin use tied to lower risk for digestive tract cancers

(HealthDay)—Regular aspirin use is associated with a lower risk for colorectal and other digestive tract cancers, according to a review published in the May 1 issue of the Annals of Oncology.

Cristina Bosetti, Ph.D., from the Istituto di Ricerche Farmacologiche Mario Negri IRCCS in Milan, and colleagues conducted a and meta-analysis of all observational studies evaluating the association between aspirin and cancers of the digestive tract sites, published through March 2019.

The researchers found that regular aspirin use is associated with a reduced risk for (relative risk [RR], 0.73 [95 percent confidence interval (CI), 0.69 to 0.78]; 45 studies), squamous cell (RR, 0.67 [95 percent CI, 0.57 to 0.79]; 13 studies), adenocarcinoma of the esophagus and gastric cardia (RR, 0.61 [95 percent CI, 0.49 to 0.77]; 10 studies), (RR, 0.64 [95 percent CI, 0.51 to 0.82]; 14 studies), hepatobiliary tract cancer (RR, 0.62 [95 percent CI, 0.44 to 0.86]; five studies), and pancreatic cancer (RR, 0.78 [95 percent CI, 0.68 to 0.89]; 15 studies). There was no association with head and neck cancer (RR, 0.94 [95 percent CI, 0.76 to 1.16]; 10 studies). Findings were similar across sex, geographical areas, and other selected covariates. An aspirin dose of 75 to 100 mg/day lowers the risk for colorectal cancer by 10 percent, while a dose of 325 mg/day is associated with a 35 percent risk reduction. There was an inverse relationship noted between duration of aspirin use and risk reduction for all cancers, except head and neck cancers.

"Taking aspirin for the prevention of bowel , or any other cancers, should only be done in consultation with a doctor, who can take account of the person's individual risk," a coauthor said in a statement.

The study was supported by Bayer.

More information: Abstract/Full Text

Journal information: Annals of Oncology

Copyright © 2020 HealthDay. All rights reserved.

Citation: Regular aspirin use tied to lower risk for digestive tract cancers (2020, May 15) retrieved 9 December 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Aspirin linked to reduction in risk of several cancers of the digestive tract


Feedback to editors